SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-041281
Filing Date
2022-02-14
Accepted
2022-02-14 15:02:01
Documents
2
Group Members
FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLCFLAGSHIP PIONEERING FUND VI, L.P.FLAGSHIP PIONEERING, INC.FLAGSHIP V VENTURELABS RX FUND, L.P.FLAGSHIP VENTURELABS V LLCFLAGSHIP VENTURES FUND V GENERAL PARTNER LLCNOUBAR B. AFEYAN, PH.D.VENTURELABS V MANAGER

Document Format Files

Seq Description Document Type Size
1 SC 13G d310337dsc13g.htm SC 13G 159172
2 EX-99.1 d310337dex991.htm EX-99.1 17350
  Complete submission text file 0001193125-22-041281.txt   178412
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Subject) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92124 | Film No.: 22630099
SIC: 2836 Biological Products, (No Diagnostic Substances)